Literature DB >> 637761

Swine influenza vaccination in patients with multiple sclerosis.

C R Bamford, W A Sibley, J F Laguna.   

Abstract

Swine influenza vaccination was tolerated well by 61 multiple sclerosis patients. A new neurologic symptom developed in one patient, one noticed the recurrence of previous symptoms, and two patients experienced systemic signs of toxicity.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 637761     DOI： 10.1001/archneur.1978.00500280060012

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


  9 in total

1.  A controlled study of potential risk factors preceding exacerbation in multiple sclerosis.

Authors:  C Gasperini; M G Grasso; M Fiorelli; E Millefiorini; S Morino; A Anzini; A Colleluori; M Salvetti; C Buttinelli; C Pozzilli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

2.  Relapse risk in patients with multiple sclerosis after H1N1 vaccination, with or without seasonal influenza vaccination.

Authors:  Nuala McNicholas; Jeremy Chataway
Journal:  J Neurol       Date:  2011-02-19       Impact factor: 4.849

Review 3.  Immunizations and risk of multiple sclerosis: systematic review and meta-analysis.

Authors:  Mauricio F Farez; Jorge Correale
Journal:  J Neurol       Date:  2011-03-24       Impact factor: 4.849

Review 4.  Pathogenesis of multiple sclerosis. A critical reappraisal.

Authors:  C M Poser
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

5.  Antibody response in seropositive multiple sclerosis patients vaccinated with attenuated live varicella zoster virus.

Authors:  R Ross; M Dawood; M Cheang; L E Nicolle
Journal:  Can J Infect Dis       Date:  1996-09

6.  Clinical viral infections and multiple sclerosis.

Authors:  W A Sibley; C R Bamford; K Clark
Journal:  Lancet       Date:  1985-06-08       Impact factor: 79.321

7.  Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination.

Authors:  M Salvetti; A Pisani; S Bastianello; E Millefiorini; C Buttinelli; C Pozzilli
Journal:  J Neurol       Date:  1995-02       Impact factor: 4.849

Review 8.  Vaccines and multiple sclerosis: a systematic review.

Authors:  Mia Topsøe Mailand; Jette Lautrup Frederiksen
Journal:  J Neurol       Date:  2016-09-07       Impact factor: 6.682

9.  Registry Cohort Study to Determine Risk for Multiple Sclerosis after Vaccination for Pandemic Influenza A(H1N1) with Arepanrix, Manitoba, Canada.

Authors:  Salaheddin M Mahmud; Songul Bozat-Emre; Luiz C Mostaço-Guidolin; Ruth Ann Marrie
Journal:  Emerg Infect Dis       Date:  2018-07       Impact factor: 6.883
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.